Exploring the immunogenicity of non-canonical HLA-I tumor ligands identified through proteogenomics.
Clinical cancer research : an official journal of the American Association for Cancer Research(2023)
摘要
Our findings predict a limited contribution of nonC-TL to cancer immunosurveillance but demonstrate they may be attractive novel targets for widely applicable immunotherapies.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要